OmniAb, Inc. (OABI) vs Pharming Group N.V. Sponsored ADR (PHAR)
- OmniAb, Inc. OABI 4.59 −2.96%
- Pharming Group N.V. Sponsored ADR PHAR 9.36 −2.80%
OmniAb, Inc. and Pharming Group N.V. Sponsored ADR are both Biotechnology companies. OmniAb, Inc. and Pharming Group N.V. Sponsored ADR are of similar size ($687.7M and $681.6M). OmniAb, Inc. has negative trailing earnings, so its P/E is not meaningful; Pharming Group N.V. Sponsored ADR trades at 62.4×. OmniAb, Inc. grew revenue faster over the last twelve months: 67.0% against 7.85%. Pharming Group N.V. Sponsored ADR has the higher net margin (2.55% vs −115.1%) and the higher return on invested capital (5.50% vs −14.5%). Across the 17 metrics below, Pharming Group N.V. Sponsored ADR leads on 13 and OmniAb, Inc. on 4.
Valuation
Profitability
| Metric | OABI | PHAR | Biotechnology median |
|---|---|---|---|
| Gross margin | 98.28% | 86.54% | 65.16% |
| Operating margin | (125.78%) | 5.04% | 0.00% |
| Net margin | (115.12%) | 2.55% | 0.00% |
| Free cash flow margin | (47.17%) | 9.38% | 0.00% |
| Return on equity | (16.95%) | 3.67% | (56.36%) |
| Return on assets | (15.11%) | 2.05% | (48.04%) |
| Return on invested capital | (14.52%) | 5.50% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack